Attached files
file | filename |
---|---|
8-K - FORM 8-K - DENDREON CORP | v58187e8vk.htm |
Exhibit 99.1
Dendreon Announces Exercise and Closing of Overallotment Option
Proceeds to Dendreon of $607.6 Million
Proceeds to Dendreon of $607.6 Million
(SEATTLE) February 3, 2011Dendreon Corporation (NASDAQ: DNDN) today announced that the
underwriter in its previously announced public offering of 2.875% convertible senior notes due
January 15, 2016 (the Notes) exercised and closed on its overallotment option in full to purchase
an additional $80 million aggregate principal amount of Notes. The sale of the Notes, including
the exercise of the overallotment option, resulted in net proceeds to Dendreon of approximately
$607.2 million after deducting underwriting fees and estimated offering expenses that are payable
by Dendreon.
The offering of the Notes was led by J.P. Morgan Securities LLC. The offering of the Notes is made
only by means of a prospectus and final prospectus supplement to Dendreons effective shelf
registration statement filed with the SEC on December 8, 2009, as amended. Printed copies of the
prospectus supplement relating to this offering may be obtained by requesting copies from J.P.
Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New
York 11717 or by calling 1-866-803-9204.
This press release does not constitute an offer to sell or the solicitation of an offer to buy
securities, nor shall there be any sales of securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any jurisdiction.
This press release includes forward-looking statements, within the meaning of the Private
Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other
factors, including the current market demand for these types of securities, and the securities of
Dendreon and the negotiations between Dendreon and the underwriter due to changes in the price of
the Common Stock, corporate or other market conditions. These risks, uncertainties and other
factors could cause actual results to differ materially from those referred to in the
forward-looking statements. The reader is cautioned not to rely on these forward-looking
statements. Other risks that could impact the Notes offering are described in detail in the
prospectus supplement, and other filings made with the Securities and Exchange Commission. Undue
reliance should not be placed on forward-looking statements, which speak only as of the date they
are made. Dendreon undertakes no obligation to update any forward-looking statements to reflect new
information, events or circumstances after the date they are made, or to reflect the occurrence of
unanticipated events.
Contact Information:
Katherine Stueland
Vice President, Corporate Communications and Investor Relations
206-829-1522
kstueland@dendreon.com
Katherine Stueland
Vice President, Corporate Communications and Investor Relations
206-829-1522
kstueland@dendreon.com